Active ingredientChlordiazepoxideCat. No. P-C131-001CAS 58-25-3Family · Pharmaceutical analytical standards
Chlordiazepoxide
The first benzodiazepine ever synthesised, made in the mid-1950s by chemist Leo Sternbach and approved in 1960; it is used for anxiety and for alcohol withdrawal symptoms. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.
Did you know?Its discovery was pure chance: only in 1957 did tests reveal the compound's anxiolytic and muscle-relaxant effects; it was originally called methaminodiazepoxide.
Go to the active ingredient →Active ingredientChlordiazepoxideCat. No. P-C131-001CAS 58-25-3
Active ingredientChlordiazepoxide HydrochlorideCat. No. P-C131-002CAS 438-41-5
Pharmacopoeial impurityChlordiazepoxide EP Impurity ACat. No. P-C131-003CAS 963-39-3
Pharmacopoeial impurityChlordiazepoxide EP Impurity BCat. No. P-C131-004CAS 5958-24-7
NitrosamineN-NitrosochlordiazepoxideCat. No. P-C131-005CAS 51715-17-4
ImpurityNorchlorodiazepoxideCat. No. P-C131-006CAS 7722-15-8No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceChlordiazepoxide CRSEDQM code C1450000Family ChlordiazepoxideReference substanceChlordiazepoxide hydrochloride CRSEDQM code C1500000Family ChlordiazepoxideImpurityChlordiazepoxide impurity A CRSEDQM code Y0000476Family ChlordiazepoxideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.